Since buparlisib appears to have an off-target liability with respect to inhibition of microtubule polymerization, the depression might be related to its disruption of tubulin polymerization in the CNS rather than to on-target activity on PI3K [54]. The gene discussed is PIK3CA; the disease is major depressive disorder.